Evidence map›Paper›PMID 24785834›Full record

ArticleImmunology letters2014

CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.

Damalie Nakanjako, Juliet Otiti-Sengeri, Isaac Ssewanyana, Rose Nabatanzi, Lois Bayigga, Samuel Kirimunda, Moses Joloba, Yukari C Manabe, Andrew Kambugu, Robert Colebunders and 1 more

Abstract read
In one paragraph

Article in Immunology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Damalie NakanjakoMakerere University College of Health Sciences, Uganda; Infectious Diseases Institute, Makerere University, Kampala, Uganda. Electronic address: dnakanjako@gmail.com.
Juliet Otiti-SengeriMakerere University College of Health Sciences, Uganda.
Isaac SsewanyanaInfectious Disease Research Collaboration, Kampala, Uganda.
Rose NabatanziMakerere University College of Health Sciences, Uganda.
Lois BayiggaMakerere University College of Health Sciences, Uganda.
Samuel KirimundaMakerere University College of Health Sciences, Uganda.
Moses JolobaMakerere University College of Health Sciences, Uganda.
Yukari C ManabeInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Andrew KambuguInfectious Diseases Institute, Makerere University, Kampala, Uganda.
Robert ColebundersUniversity of Antwerp, Belgium; Institute of Tropical Medicine, Antwerp, Belgium.
Harriet Mayanja-KizzaMakerere University College of Health Sciences, Uganda.
Makerere University · UGInfectious Diseases Institute · UGInfectious Diseases Research Collaboration · UG

Funding

University of California Launching Future Leaders in Global Health Research Training ProgramD43TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CRAIG R COHEN, Sung-Jae Lee · 2017 to 2026
$14.7M
University of California Global Health Institute Program for Fellows and ScholarsR25TW009343 · FIC · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COHEN, CRAIG R, STRATHDEE, STEFFANIE A. · 2012 to 2017
$6.4M
Training of Ugandans in Basic Research on TB and Emerging Infectious DiseasesD43TW009093 · FIC · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ELLNER, JERROLD J. · 2014 to 2023
$2.2M
FIC NIH HHS D43 TW009093FIC NIH HHS D43 TW009343FIC NIH HHS R25 TW009343Wellcome Trust 084344
6 · The paper itself

Abstract

backgroundCataracts contribute 12% of visual loss among HIV-infected adults in Uganda. Immuno-pathogenesis of cataracts may differ among HIV-infected individuals; thus the need for innovative therapeutic interventions among HIV-infected adults.

methodsIn a laboratory based case-control study, nested in a clinical/surgical community outreach camp, 50 adults with cataracts eligible for surgery were selected consecutively. HIV testing was done for individuals with unknown HIV sero-status. Peripheral Blood Mononuclear Cells (PBMC) were collected from all HIV-positive-adults-with-cataracts (cases) and HIV-negative-adults-with-cataracts (comparative group) and age-matched HIV-negative and HIV-positive-adults-without-cataracts (comparative group). Treg were measured as CD3+CD4+FoxP3+CD25+(Bright) and immune activation as CD3+CD4+CD38+HALDR+ using a Facs Canto II flowcytometer. Mann Whitney test was used to compare expression among the four groups.

resultsOf 50 adults operated for cataracts, 24 (48%) were female, 25 (50%) were HIV-positive. HIV-positive-individuals had cataracts earlier [median; Inter-quartile Range (IQR); 49 (44-53) years] than HIV-negative [70 (IQR 59-75) years]; p=0.0005. Treg were lower among individuals with cataracts irrespective of HIV status; p=0.001; but comparable among younger HIV-positive and elderly HIV-negative with cataracts; p=0.301. Immune activation levels were comparable among HIV-positive and HIV-negative individuals with cataracts. However, HIV-positive-individuals with cataracts expressed higher levels of immune activation than HIV-positive-individuals without cataracts; p=0.012 and HIV-negative-individuals-with-cataracts expressed higher levels of immune activation that HIV-negative-without-cataracts; p<0.0001.

conclusionCD4 T-cell activation and reduced regulatory T-cell populations were associated with cataracts among adults aging with HIV. We recommend studies on clinical relevance of immune modulation in the prevention of early development of cataracts among adults aging with HIV in Africa.

Indexed as

AdultAgedAntigens, SurfaceCase-Control StudiesCataractCD4-Positive T-LymphocytesFemaleHIV InfectionsHumansImmunophenotypingLymphocyte ActivationLymphocyte CountMaleMiddle AgedT-Lymphocytes, RegulatoryUgandaAntigens, SurfaceAgingBlinding CataractsHIV/AIDSImmune activationRegulatory T-cellsSub-Saharan Africa

Identifiers

PMID24785834
PMCPMC4907352
OpenAlexW2051811558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.